| BUSINESS STRATEGY | Co saw potential in making discovery libraries for life sciences companies and by 2000 had developed a network of eight laboratories in Eastern Europe, with main operations in Moscow; Kiev; and Kharkov, Ukraine. The firm's strategy is for different labs to carry out different steps--chemistry research, building block scale-up, library validation--in large multiparallel synthesis programs. |
| CORP. FOCUS |
Co was set up to handle more customized work for North American and Japanese customers. Contact `L` a medicinal chemistry veteran who joined CDL earlier this year as vice president of chemistry, says being local is important for companies that are "concerned with the safety of their intellectual property." Plus, the time difference with Russia can be an issue in complex iterative research projects, he says. |
| CORP. INFORMATION | Co is fastest growing operation today. Laboratory space in San Diego was tripled in February, and its staff of 40 chemists is on track to double by the end of the year. Co maintains that reasons for expanding operations in the U.S. include faster project turnaround time and lower costs for intermediates and research equipment services. Co don't emphasize any difference in overall costs that might exist between the Eastern European and U.S. locations |
| PRODUCT | Co produce a few hundred thousand small-molecule compounds per year that go into both diverse and targeted libraries for lead discovery. They also make proprietary building blocks in quantities ranging from grams to kilograms |
| UPDATE | 09.02 |
| COMPANY | This data is not available for free |
| CONTACT | This data is not available for free |
| CORP. HISTORIC | Founded in 1999 |
| CUSTOMER | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
| SUBSIDIARY OF | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |